{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:16:12Z","timestamp":1783149372057,"version":"3.54.6"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.7759\/cureus.112027","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:25:26Z","timestamp":1783146326000},"source":"Crossref","is-referenced-by-count":0,"title":["Marked Asymptomatic Creatine Kinase Elevation With Preserved Renal Function Identified Through Protocol-Driven Monitoring in a Clinical Trial Participant: A Case Report"],"prefix":"10.7759","author":[{"given":"Raymond T","family":"Anasobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taranjeet","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldm014","article-title":"Creatine kinase monitoring in sport medicine","volume":"81-82","author":"Brancaccio P","year":"2007","unstructured":"Brancaccio P, Maffulli N, Limongelli FM. Creatine kinase monitoring in sport medicine. Br Med Bull. 2007, 81-82:209-30. 10.1093\/bmb\/ldm014","journal-title":"Br Med Bull"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2016-000151","article-title":"Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy?","volume":"2","author":"Scalco RS","year":"2016","unstructured":"Scalco RS, Snoeck M, Quinlivan R, Treves S, Lafor\u00e9t P, Jungbluth H, Voermans NC. Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy?. BMJ Open Sport Exerc Med. 2016, 2:e000151. 10.1136\/bmjsem-2016-000151","journal-title":"BMJ Open Sport Exerc Med"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1097\/00002060-200211001-00007","article-title":"Exercise-induced muscle damage in humans","volume":"81","author":"Clarkson PM","year":"2002","unstructured":"Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil. 2002, 81:52-69.","journal-title":"Am J Phys Med Rehabil"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"Baird MF","year":"2012","unstructured":"Baird MF, Graham SM, Baker JS, Bickerstaff GF. Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery. J Nutr Metab. 2012, 2012:960363. 10.1155\/2012\/960363","journal-title":"J Nutr Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1941738114523544","article-title":"Exertional rhabdomyolysis in the athlete: a clinical review","volume":"6","author":"Tietze DC","year":"2014","unstructured":"Tietze DC, Borchers J. Exertional rhabdomyolysis in the athlete: a clinical review. Sports Health. 2014, 6:336-9. 10.1177\/1941738114523544","journal-title":"Sports Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.108555","article-title":"Progressive asymptomatic hyperglycemia and glucosuria identified through protocol-driven monitoring in a clinical trial: a case report","volume":"18","author":"Anasobi RT","year":"2026","unstructured":"Anasobi RT, Stewart O, Stumbris R. Progressive asymptomatic hyperglycemia and glucosuria identified through protocol-driven monitoring in a clinical trial: a case report. Cureus. 2026, 18:e108555. 10.7759\/cureus.108555","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch X","year":"2009","unstructured":"Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009, 361:62-72. 10.1056\/NEJMra0801327","journal-title":"N Engl J Med"},{"key":"ref8","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres PA","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015, 15:58-69.","journal-title":"Ochsner J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jshs.2015.01.012","article-title":"Exercise-induced rhabdomyolysis mechanisms and prevention: a literature review","volume":"5","author":"Kim J","year":"2016","unstructured":"Kim J, Lee J, Kim S, Ryu HY, Cha KS, Sung DJ. Exercise-induced rhabdomyolysis mechanisms and prevention: a literature review. J Sport Health Sci. 2016, 5:324-33. 10.1016\/j.jshs.2015.01.012","journal-title":"J Sport Health Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3892\/br.2016.822","article-title":"Asymptomatic hyperCKemia during a two-year monitoring period: a case report and literature overview","volume":"6","author":"Klinis S","year":"2017","unstructured":"Klinis S, Symeonidis A, Karanasios D, Symvoulakis EK. Asymptomatic hyperCKemia during a two-year monitoring period: a case report and literature overview. Biomed Rep. 2017, 6:79-82. 10.3892\/br.2016.822","journal-title":"Biomed Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12791","article-title":"Asymptomatic hyperCKemia: a diagnostic trap","volume":"13","author":"Shaikh S","year":"2021","unstructured":"Shaikh S, Gonzalez-Zapata A, Mujeeb A, Rauf A, Thekkemuriyil D. Asymptomatic hyperCKemia: a diagnostic trap. Cureus. 2021, 13:e12791. 10.7759\/cureus.12791","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2012.01.004","article-title":"Statin induced myotoxicity","volume":"23","author":"Sathasivam S","year":"2012","unstructured":"Sathasivam S. Statin induced myotoxicity. Eur J Intern Med. 2012, 23:317-24. 10.1016\/j.ejim.2012.01.004","journal-title":"Eur J Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1445324","article-title":"Rhabdomyolysis associated with concomitant use of colchicine and statins in the real world: identifying the likelihood of drug-drug interactions through the FDA adverse event reporting system","volume":"15","author":"Zhang S","year":"2024","unstructured":"Zhang S, Yan MM, Zhao H, Qiu XY, Zhu D. Rhabdomyolysis associated with concomitant use of colchicine and statins in the real world: identifying the likelihood of drug-drug interactions through the FDA adverse event reporting system. Front Pharmacol. 2024, 15:1445324. 10.3389\/fphar.2024.1445324","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501986-marked-asymptomatic-creatine-kinase-elevation-with-preserved-renal-function-identified-through-protocol-driven-monitoring-in-a-clinical-trial-participant-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:25:27Z","timestamp":1783146327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501986-marked-asymptomatic-creatine-kinase-elevation-with-preserved-renal-function-identified-through-protocol-driven-monitoring-in-a-clinical-trial-participant-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.112027","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}